Hiroz Philippe, Antonino Anca, Doerig Christopher, Pache Isabelle, Moradpour Darius
Service de gastroentérologie et d'hépatologie, CHUV, 1011 Lausanne.
Rev Med Suisse. 2011 Sep 7;7(307):1690-2, 1694-5.
Wilson disease (WD) is an inherited disorder of hepatic copper excretion leading to toxic accumulation of copper in the liver as well as the brain, cornea, and other organs. The defect is due to mutations of the copper-transporting ATPase ATP7B. Clinical manifestations are highly variable and comprise acute liver failure, chronic hepatitis and cirrhosis as well as neurological or psychiatric symptoms. The Kayser-Fleischer corneal ring is pathognomonic but absent in about 50% of patients with hepatic manifestations alone. A high index of suspicion in clinically compatible situations is key, with a combination of laboratory tests allowing the diagnosis of WD. Treatment is based on the use of chelating agents, D-penicillamine or trientine. Liver transplantation should be considered for patients with acute liver failure or advanced cirrhosis.
威尔逊病(WD)是一种遗传性肝脏铜排泄障碍疾病,会导致铜在肝脏以及大脑、角膜和其他器官中蓄积中毒。该缺陷是由铜转运ATP酶ATP7B的突变引起的。临床表现高度多变,包括急性肝衰竭、慢性肝炎和肝硬化以及神经或精神症状。凯泽尔-弗莱舍尔角膜环具有诊断特异性,但仅出现肝脏表现的患者中约50%没有此体征。在临床症状相符的情况下保持高度怀疑是关键,结合实验室检查可诊断WD。治疗基于使用螯合剂、D-青霉胺或曲恩汀。急性肝衰竭或晚期肝硬化患者应考虑肝移植。